Cancer treatment with c-met antagonists and correlation of the latter with hgf expression

MA39776AUndetermined Publication Date: 2017-02-01F HOFFMANN LA ROCHE & CO AG +1

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: MA39776
Authority / Receiving Office: MA · MA
Patent Type: Applications
Current Assignee / Owner
Priority Date: 2014-04-28
Filing Date: 2015-03-24
Publication Date: 2017-02-01

Application Information

Patent Timeline

28 Apr 2014

Priority

24 Mar 2015

Application

MA39776

01 Feb 2017

Publication

MA39776A

IPC: C12Q1/68

CPC: A61K39/39558; A61K45/00; A61K45/06; C12Q1/6886; A61K2039/507; A61K2039/545; C12Q2600/158; A61K2300/00

Inventors: KOEPPEN Hartmut; PHAN See

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

The present invention concerns cancer biomarkers. In particular, the invention concerns hgf as a biomarker for patient selection and patient prognosis in cancer, as well as methods of therapeutic treatment, articles of manufacture and methods for making them, diagnostic kits, methods of detection and methods of advertising related thereto.

Need to check novelty before this filing date? Find Prior Art